Evidence map›Paper›PMID 32646040›Full record

ArticleMolecules (Basel, Switzerland)2020

A Nano Drug Delivery System Based on

Min-Zhe Wang, Xin He, Zhe Yu, Hong Wu, Tie-Hong Yang

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Review
  3. Materials today. Bio · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Min-Zhe WangDepartment of Medicine Chemistry and Pharmaceutical Analysis, School of Pharmacy, Air Force Medical University, Xi'an 710032, China.
Xin HeDepartment of Medicine Chemistry and Pharmaceutical Analysis, School of Pharmacy, Air Force Medical University, Xi'an 710032, China.
Zhe YuDepartment of Medicine Chemistry and Pharmaceutical Analysis, School of Pharmacy, Air Force Medical University, Xi'an 710032, China.
Hong WuDepartment of Medicine Chemistry and Pharmaceutical Analysis, School of Pharmacy, Air Force Medical University, Xi'an 710032, China.
Tie-Hong YangDepartment of Medicine Chemistry and Pharmaceutical Analysis, School of Pharmacy, Air Force Medical University, Xi'an 710032, China.
Air Force Medical University · CN

Funding

National Natural Science Foundation of China Grant No. 31671015National Natural Science Foundation of China Grant No. 81373948Shaanxi Science & Technology for Social Development Project 2015SF077
6 · The paper itself

Abstract

Combination of chemotherapy and immunotherapy has been a promising strategy in cancer treatment. Polysaccharides from

Indexed as

DoxorubicinDrug CarriersImmunotherapyNanoparticlesPolysaccharidesA549 CellsAngelica sinensisAnimalsDelayed-Action PreparationsHumansMCF-7 CellsMiceNeoplasms, ExperimentalTh1 CellsTh2 CellsTumor MicroenvironmentDelayed-Action PreparationsDoxorubicinDrug CarriersPolysaccharidesAngelica sinensis polysaccharidedoxorubicinenzymes sensitive drug deliverysynergistic therapy

Identifiers

PMID32646040
PMCPMC7411593
OpenAlexW3038361180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.